Dr. David Bernard Miklos, MDPHD is a Hematology / Oncology Specialist - Hematologist (Blood) practicing in Stanford, CA
He has not yet shared a personalized biography with Doctor.com.
| University | Degree | Focus | Graduated |
|---|---|---|---|
| Yale University School of Medicine | Medical Degree | 1995 |
| Institution | Focus | Year |
|---|---|---|
| Internship - Peter Bent Brigham Hospital/Harvard University | 1996 | |
| Residency - Brigham and Women's Hospital Harvard Medical School | 1998 | |
| Residency - Brigham & Women's Hospital Program | Not Specified | |
| Fellowship - Dana Farber Cancer Institute | 2001 |
| Position | Organization | Time |
|---|---|---|
| Assistant Professor of Medicine (Blood and Marrow Transplantation) | the Stanford University Medical Center | Present |
| Publication | Publisher | Title | Published |
|---|---|---|---|
| Other Publication | BLOOD | A distinct evolution of the T | 2013 |
| Other Publication | PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM | H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells | 2013 |
| Other Publication | PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM | High-throughput VDJ sequencing for quantification of minimal residual disease in chronic | 2011 |
| Other Publication | SCIENCE TRANSLATIOL MEDICINE | Measurement and Clinical Monitoring of Human Lymphocyte Clolity by Massively Parallel V-D | 2009 |
| Other Publication | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | Birth Order and Transplantation Outcome in HLA-Identical Sibling Stem Cell Transplantation | 2013 |
| Other Publication | BONE MARROW TRANSPLANTATION | Clolly identical Hodgkin's disease develops after allogeneic hematopoietic cell transplant for CLL | 2011 |
| Other Publication | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | The Outcomes of Family Haploidentical Hematopoietic Stem Cell Transplantation | 2011 |
| Other Publication | TURE MEDICINE | B cells promote insulin resistance through modulation of T cells | 2011 |
| Other Publication | BONE MARROW TRANSPLANTATION | Long-term outcomes in patients with high | 2011 |
| Other Publication | Methods in molecular biology (Clifton, N.J.) | Recombint antigen microarrays for serum/plasma antibody detection. | 2011 |
| Other Publication | BRITISH JOURL OF HAEMATOLOGY | Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular | 2010 |
| Other Publication | Proceedings of the tiol Academy of Sciences of the United States of Am | Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation. | 2010 |
| Other Publication | JOURL OF IMMUNOLOGY | Individual Variation in the Germline Ig Gene Repertoire Inferred from Variable Region Gene | 2010 |
| Other Publication | PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM | Identifying compartment-specific non | 2009 |
| Other Publication | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | B Cells and Transplantation: An Educatiol Resource | 2009 |
| Other Publication | MODERN PATHOLOGY | Rel pathology in hematopoietic cell transplantation recipients | 2008 |
| Other Publication | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | Toward biomarkers for chronic graft-versus-host disease | 2006 |
| Other Publication | LEUKEMIA | Minimal residual disease quantification using consensus primers | 2013 |
| Other Publication | BLOOD | A distinct evolution of the T | 2013 |
| Other Publication | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O | H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells | 2013 |
| Other Publication | BLOOD | Massive evolution of the immunoglobulin heavy chain locus | 2012 |
| Other Publication | BLOOD | Prophylactic rituximab after allogeneic transplantation decreases B | 2012 |
| Other Publication | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O | High-throughput VDJ sequencing for quantification of minimal residual disease in chronic | 2011 |
| Other Publication | SCIENCE TRANSLATIONAL MEDICINE | Measurement and Clinical Monitoring of Human Lymphocyte Clonality by Massively Parallel V-D | 2009 |
| Other Publication | BLOOD | Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft | 2005 |
| Other Publication | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | Birth Order and Transplantation Outcome in HLA-Identical Sibling Stem Cell Transplantation | 2013 |
| Other Publication | VIRAL IMMUNOLOGY | Humoral Immunity to Cytomegalovirus and Chronic Graft-Versus-Host Disease | 2012 |
| Other Publication | BONE MARROW TRANSPLANTATION | Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative | 2012 |
| Other Publication | BONE MARROW TRANSPLANTATION | Clonally identical Hodgkin's dise | 2011 |
| Other Publication | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | Adoptive Immunotherapy with Cytokine | 2011 |
| Other Publication | BLOOD | A phase 1 study of imatinib for corticosteroid-dependent | 2011 |
| Other Publication | TRANSPLANTATION | Combined CD4 T-Cell | 2011 |
| Other Publication | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | The Outcomes of Family Haploidentical Hematopoietic Stem Cell Transplantation | 2011 |
| Other Publication | NATURE MEDICINE | B cells promote insulin resistance through modulation of T cells | 2011 |
| Other Publication | MOLECULAR & CELLULAR PROTEOMICS | Protein Microarrays Discover Angiotensinogen | 2011 |
| Other Publication | BONE MARROW TRANSPLANTATION | Long-term outcomes in patients with high | 2011 |
| Other Publication | Methods in molecular biology (Clifton, N.J.) | Recombinant antigen microarrays for serum/plasma antibody detection. | 2011 |
| Other Publication | BLOOD | Outcomes of pediatric bone marrow transplantation for leukemia | 2010 |
| Other Publication | HUMAN REPRODUCTION | H-Y antibody titers are increased in unexplained secondary recurrent miscarriage patients | 2010 |
| Other Publication | BRITISH JOURNAL OF HAEMATOLOGY | Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular | 2010 |
| Other Publication | Proceedings of the National Academy of Sciences of the United States o | Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation. | 2010 |
| Other Publication | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | Phase I/II Trial of GN-BVC | 2010 |
| Other Publication | JOURNAL OF IMMUNOLOGY | Individual Variation in the Germline Ig Gene Repertoire Inferred from Variable Region Gene | 2010 |
| Other Publication | EXPERT OPINION ON BIOLOGICAL THERAPY | Rituximab in hematopoietic cell transplantation | 2010 |
| Other Publication | BLOOD | Antibodies specifically target AML antigen NuSAP1 after allogeneic bone marrow transplantation | 2010 |
| Other Publication | BLOOD | TLI and ATG conditioning with low risk of graft-versus | 2009 |
| Other Publication | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O | Identifying compartment-specific non | 2009 |
| Other Publication | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | B Cells and Transplantation: An Educational Resource | 2009 |
| Other Publication | TRANSPLANTATION | H-Y antibody development associates with acute rejection in female patients with male kidney | 2008 |
| Other Publication | MODERN PATHOLOGY | Renal pathology in hematopoietic cell transplantation recipients | 2008 |
| Other Publication | BLOOD | Rituximab for steroid-refractory chronic graft-versus-host disease | 2006 |
| Other Publication | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | Toward biomarkers for chronic graft-versus-host disease | 2006 |
| Other Publication | BLOOD | Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell | 2004 |
Dr. David Bernard Miklos, MDPHD has not yet indicated the hospitals that he is affiliated with.
Accepts New Patients: Yes
Dr. David Bernard Miklos, MDPHD has not yet listed the medications that he commonly prescribes.
Dr. David Bernard Miklos, MDPHD has not yet added any information about his practice's billing policies and payment options.
